Search research articles
Contact Us
Filters
Showing results (1-10 of 4) with videos related to
Page
of 1
Sort By:
The Journal of Organic Chemistry
|
July 12, 1996
Cyclopentene Synthesis from 1,3-Dienes via Base-Induced Ring Contraction of 3,6-Dihydro-2H-thiopyrans: Studies on Diastereoselection and Mechanism
Scott D. Larsen, Peter V. Fisher, Brian E. Libby, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 15, 2007
Cyclic benzamidines as orally efficacious NR2B-selective NMDA receptor antagonists
Kevin T Nguyen, Christopher F Claiborne, John A McCauley, et al.
Journal of Medicinal Chemistry
|
January 26, 2007
Identification and characterization of 4-methylbenzyl 4-[(pyrimidin-2-ylamino)methyl]piperidine-1-carboxylate, an orally bioavailable, brain penetrant NR2B selective N-methyl-D-aspartate receptor antagonist
Nigel J Liverton, Rodney A Bednar, Bohumil Bednar, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 18, 2003
Orally efficacious NR2B-selective NMDA receptor antagonists
Christopher F Claiborne, John A McCauley, Brian E Libby, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 4) with videos related to
Sort By:
Page
of 1
The Journal of Organic Chemistry
|
July 12, 1996
Cyclopentene Synthesis from 1,3-Dienes via Base-Induced Ring Contraction of 3,6-Dihydro-2H-thiopyrans: Studies on Diastereoselection and Mechanism
Scott D. Larsen, Peter V. Fisher, Brian E. Libby, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 15, 2007
Cyclic benzamidines as orally efficacious NR2B-selective NMDA receptor antagonists
Kevin T Nguyen, Christopher F Claiborne, John A McCauley, et al.
Journal of Medicinal Chemistry
|
January 26, 2007
Identification and characterization of 4-methylbenzyl 4-[(pyrimidin-2-ylamino)methyl]piperidine-1-carboxylate, an orally bioavailable, brain penetrant NR2B selective N-methyl-D-aspartate receptor antagonist
Nigel J Liverton, Rodney A Bednar, Bohumil Bednar, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 18, 2003
Orally efficacious NR2B-selective NMDA receptor antagonists
Christopher F Claiborne, John A McCauley, Brian E Libby, et al.
Page
of 1